INmune Bio releases new investor presentation; no financial updates in filing

Inmune Bio, Inc.

Company furnished a slide deck for use in investor presentations (Exhibit 99.1).
Deck posted on company website under 'Investors – Corporate Presentation' section.
Filing contains no new financial results, clinical data, or guidance changes.
Presentation includes forward-looking statements; no material events disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.